Abstract
Background
Little is known about breast cancer management among Asian Americans and Pacific Islanders (AAPI).
Methods
We performed a retrospective analysis of 2030 women (935 Japanese, 144 Chinese, 235 Filipino, 293 Hawaiian, and 423 white; mean age ± SD, 59 ± 13 years) with a diagnosis of early breast cancer (stages I, II, and IIIA) in Hawaii from 1995 to 2001. We linked data from the Surveillance, Epidemiology, and End Results program’s Hawaii Tumor Registry to administrative health care claims. We evaluated (1) breast-conserving surgery (BCS); (2) radiotherapy after BCS; and (3) chemotherapy for node-positive disease. We used logistic regression to examine the association between AAPI ethnicity and treatment, adjusting for age, year, rural residence, tumor size, grade, nodal status, receptor status, prior cancer, comorbidity index, health plan type, and income.
Results
Overall, 60.3% of women had stage I disease, 36.8% had stage II, and 2.9% had stage IIIA. Only 55.6% received BCS, and 85.1% of these women also received radiation. Of those with nodal involvement (n = 521), 82.7% received chemotherapy. Japanese and Filipino women were significantly less likely than white women to undergo BCS (for Japanese: adjusted odds ratio, 0.62; 95% confidence interval, 0.48–0.80; for Filipinos: adjusted odds ratio, 0.47; 95% confidence interval, 0.33–0.66). Filipinos tended to be less likely than white women to receive radiation after BCS (adjusted odds ratio, 0.80; 95% confidence interval, 0.42–1.49). AAPI women were as likely as white women to receive adjuvant chemotherapy for nodal spread.
Conclusions
We found disparities in the management of early-stage breast cancer among AAPI women, particularly among Japanese and Filipinos. Further study is needed to determine the reasons for the observed disparities and to understand their effect on health outcomes.
Similar content being viewed by others
References
American Cancer Society. Cancer Facts and Figures 2005. Atlanta: American Cancer Society, 2005
Early Breast Cancer Trialists’ Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 1992;339:1–15
Early Breast Cancer Trialists’ Collaborative Group. Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. N Engl J Med 1995;333:1444–55
Treatment of Early-Stage Breast Cancer. NIH Consensus Statement 1990 Jun 18–21; 8:1–19. Available: http://www.consensus.nih.gov/1990/1990EarlyBreastCancer081html.htm [accessed April 5, 2006]
Adjuvant therapy for breast cancer. NIH Consensus Statement 2000 November 1–3; 17(4):1–35. Available: http://www.consensus.nih.gov/2000/2000AdjuvantTherapyBreastCancer114html.htm [accessed April 5, 2006]
Mandelblatt JS, Berg CD, Meropol NJ, et al. Measuring and predicting surgeons’ practice styles for breast cancer treatment in older women. Med Care 2001;39:228–42
Morrow M, White J, Moughan J, et al. Factors predicting the use of breast-conserving therapy in stage I and II breast carcinoma. J Clin Oncol 2001;19:2254–62
Albain KS, Green SR, Lichter AS, et al. Influence of patient characteristics, socioeconomic factors, geography, and systemic risk on the use of breast-sparing treatment in women enrolled in adjuvant breast cancer studies: an analysis of two intergroup trials. J Clin Oncol 1996;14:3009–17
Potosky AL, Merrill RM, Riley GF, et al. Breast cancer survival and treatment in health maintenance organization and fee-for-service settings. J Natl Cancer Inst 1997;89:1683–91
Joslyn SA. Racial differences in treatment and survival from early-stage breast carcinoma. Cancer 2002;95:1759–66
Li CI, Malone KE, Daling JR. Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med 2003;163:49–56
Zippin C, Lum D, Hankey BF. Completeness of hospital cancer case reporting from the SEER Program of the National Cancer Institute. Cancer 1995;76:2343–50
Fritz A, Ries L. The SEER Program Code Manual. 3rd ed. US Department of Health and Human Services: National Cancer Institute, 1998
Percey C, Van Holten V, Muir C, (eds). International Classification of Diseases for Oncology. 2nd ed. Geneva, Switzerland: World Health Organization, 1990
National Cancer Institute. Breast Cancer Physician Data Query. Available: http://www.cancer.gov/cancertopics/pdq/treatment/breast/HealthProfessional [accessed April 5, 2006]
Krieger N. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health 1992;82:703–10
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373–83
Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613–9
Klabunde CN, Warren JL, Legler JM. Assessing comorbidity using claims data: an overview. Med Care 2002;40(8 Suppl):IV26–35
Malin JL, Kahn KL, Adams J, Kwan L, Laouri M, Ganz PA. Validity of cancer registry data for measuring the quality of breast cancer care. J Natl Cancer Inst 2002;94:835–44
Malin JL, Schuster MA, Kahn KA, Brook RH. Quality of breast cancer care: what do we know? J Clin Oncol 2002;20:4381–93
Du XL, Key CR, Osborne C, Mahnken JD, Goodwin JS. Discrepancy between consensus recommendations and actual community use of adjuvant chemotherapy in women with breast cancer. Ann Intern Med 2003;138:90–7
Maskarinec G, Dhakal S, Yamashiro G, Issell BF. The use of breast conserving surgery: linking insurance claims with tumor registry data. BMC Cancer 2002;2:3
Morris CR, Cohen R, Schlag R, Wright WE. Increasing trends in the use of breast-conserving surgery in California. Am J Public Health 2000;90:281–4
Prehn AW, Topol B, Stewart S, Glaser SL, O’Connor L, West DW. Differences in treatment patterns for localized breast carcinoma among Asian/Pacific Islander women. Cancer 2002;95:2268–75
Goel MS, Burns RB, Phillips RS, Davis RB, Ngo-Metzger Q, McCarthy EP. Trends in breast conserving surgery among Asian Americans and Pacific Islanders, 1992-2000. J Gen Intern Med 2005;20:604–11
Potosky AL, Riley GF, Lubitz JD, Mentnech RM, Kessler LG. Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care 1993;31:732–48
Institute of Medicine. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: National Academy Press, 2002
Acknowledgments
Supported by grant R24 HS11627 from the Agency for Healthcare Research and Quality.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gelber, R.P., McCarthy, E.P., Davis, J.W. et al. Ethnic Disparities in Breast Cancer Management Among Asian Americans and Pacific Islanders. Ann Surg Oncol 13, 977–984 (2006). https://doi.org/10.1245/ASO.2006.08.036
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/ASO.2006.08.036